期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (8)
Background: Depression is considered as one of the most common neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) patients. Prescription of a......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (9)
Background: Tourette syndrome (TS) is a neurodevelopmental disorder characterised by involuntary muscle movements manifesting as motor and vocal tics.......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (9)
Background: There have been a few systematic reviews and conventional meta-analyses reporting effect of drugs on metabolic disturbance induced by atyp......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (6)
Background: Dopamine transporter (DAT) and serotonin transporter (SERT) are targets for many psychoactive substances. Functional assays including upta......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, ; ()
Background: While romantic jealousy may help to maintain relationships, following partner infidelity and an irretrievable loss of trust it can also pr......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, ; ()
Background: Long-term morphine use is associated with serious side effects, such as morphine-induced hyperalgesia and analgesic tolerance. Previous in......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (3)
Background: d-glutamate, which is involved in N-methyl-d-aspartate receptor modulation, may be associated with cognitive ageing. Aims: This study aime......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (1)
Background: Feedback evaluation of actions and error response detection are critical for optimizing behavioral adaptation. Oxytocin can facilitate lea......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (1)
Background: Disturbances of microRNA-195 have been implicated in the pathogenesis of schizophrenia. However, microRNA-195 levels in schizophrenia are ......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2021; 35 (3)
Background: Knowledge regarding the impact of body composition measures on pharmacokinetics of antipsychotics is limited. Aims: Our aim was to investi......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2020; 34 (4)
Background: Fast-acting and cognitive-enhancing antidepressants are desperately needed. Activation of translocator protein (18 kDa, TSPO) is a novel s......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2020; 34 (5)
Background: Sarcosine (N-methylglycine), a type 1 glycine transporter inhibitor (GlyT1), has shown therapeutic potential for treating schizophrenia; h......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2020; 34 (4)
Background: Identifying neural substrates that are differentially affected by drugs of abuse and natural rewards is key to finding a target for an eff......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2020; 34 (7)
Background: trans-Resveratrol has been extensively investigated for its anti-inflammatory, antioxidant, and anti-psychiatric properties. However, whet......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2020; 34 (12)
Background: A potent acetylcholinesterase inhibitor, donepezil is a cognitive enhancer clinically used to treat neurodegenerative diseases. However, i......
